GoAI
今すぐ始める
Yarrow Bioscience Inc

Yarrow Bioscience Inc

YARW

NASDAQHealthcareBiotechnology

GoAI で開く

最新データ

$18.90

+$0.30 · +1.61%

読み込み中

YARWの企業概要

企業プロフィール

Yarrow Bioscience is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The Company's lead product candidate, YB-101, is a potential first-in-class anti-thyroid stimulating hormone receptor (TSHR) monoclonal antibody designed to directly and rapidly disrupt the central mechanism of both Graves' disease (GD) and thyroid eye disease (TED).